Important discoveries have improved our understanding of the pathogenesis of many disorders characterized by neurologic dysfunction. In several of these disorders, new diagnostic tools and therapies have been developed, tested, and adopted. However, the pace of discovery in the basic and clinical neurosciences has made it challenging for child neurologists to determine which molecular diagnostic strategies, neuroimaging tools, or innovative therapies should be adopted to manage not only common ailments but also the estimated 1500 rare neurologic diseases.
In 2001, the National Institutes of Health (NIH) funded a 5-year conference grant (1 R13 NS40925-01) titled "Neurobiology of Disease in Children." In 2005, funding was extended for another 5 years (2006) (2007) (2008) (2009) (2010) . The overall goal is to bring together clinicians, scientists, caregivers, and National Institutes of Health program officers to determine how research findings can be translated to enhance clinical understanding and affect clinical practice.
Rett syndrome was selected as the topic for the most recent symposium, the fourth in the series (neurofibromatosis, leukodystrophy, and tuberous sclerosis complex were the topics of the first three conferences). The conference-directed by two highly respected leaders in the field of Rett syndrome, Drs Alan Percy and Carolyn Schanen-included formal presentations, question-andanswer sessions, panel discussions, and open discussions to directly address conference objectives. The directors chose speakers and moderators who were experts in the field to ensure authoritative presentations on key topics and productive discussions. The question-and-answer sessions after each set of talks provided an opportunity for panelists and the audience of child neurologists to brainstorm about the best directions for future research and how clinicians can contribute. The conference was divided into topical themes as follows.
The first presentation, "Clinical Issues," described Rett syndrome as a model of a neurodevelopmental disorder in which clinical profiles and variants vary with age. The audience was then introduced to molecular diagnostic strategies to address MECP2 mutations.
The second session, "Clinical and Basic Neurobiology," described the neurophysiologic and neuropathologic aspects of Rett syndrome. A detailed discussion was held on neural networks and implications for neural development.
In the third session, "Clinical Progress," speakers discussed the natural history of the disorder, phenotype-genotype correlations, and newborn screening strategies and their potential implications for therapy.
The final session, "Future Directions," opened with a presentation by Dr Story Landis, director of the National Institute of Neurologic Disorders and Stroke (NINDS), on strategic research priorities in Rett syndrome and other neurodevelopmental disorders. This session included a panel discussion moderated by Dr Laura Mamounas from the National Institute of Neurologic Disorders and Stroke that contributed insights from representatives of the International Rett Syndrome Association and the Rett Syndrome Foundation.
I wish to express my sincere appreciation to the National Institute of Neurologic Disorders and Stroke, the Child Neurology Society, and the International Rett Syndrome Association for cosponsoring the conference. Also, I thank Drs Percy and Schanen for directing a superb symposium on Rett syndrome. Finally, I wish to express my deep gratitude to all those members of the Child Neurology Society who have steadfastly supported the conference series by attending them and actively participating in question-and-answer sessions.
One of the specific aims of the "Neurobiology of Disease in Children" conferences is to disseminate the proceedings of the symposia to ensure that clinicians and basic scientists are informed about scientific advances, current research initiatives, and future directions. This issue of the Journal of Child Neurology features a series of articles prepared by conference participants and the verbatim transcript of the conference's question-and-answer sessions, panel discussions, and open discussions.
We have selected Tourette syndrome as the topic for the fifth "Neurobiology of Disease in Children" conference, which will be held September 28, 2005, in Los Angeles. In keeping with the objectives of the original proposal and the past four conferences, Drs Harvey Singer and Wayne Goodman, conference directors, have prepared a superb agenda that includes a panel of the most highly respected leaders in the field of Tourette syndrome. We look forward to seeing you in Los Angeles for another exciting symposium!
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